INTERNATIONAL PATENT: MEDILINK THERAPEUTICS (SUZHOU) CO., LTD., 苏州宜联生物医药有限公司 FILES APPLICATION FOR "USE OF ANTI-B7H3 ANTIBODY-DRUG CONJUGATE IN PREPARATION OF DRUG FOR TREATING NASOPHARYNGEAL CARCINOMA AND/OR LYMPHOEPITHELIOMA-LIKE CARCINOMA"

Posted On: 2025-03-31

GENEVA, March 31 -- MEDILINK THERAPEUTICS (SUZHOU) CO., LTD. (Unit 101, Block B3, Biopharmaceutical Industrial Park, 218 Xinghu Street, Suzhou Industrial Park, Suzhou Area of China (Jiangsu) Pilot Free Trade ZoneSuzhou, Jiangsu 215000), 苏州宜联生物医药有限公司 (中国江苏省苏州市自由贸易试验区苏州片区苏州工业园区星湖街218号生物医药产业园B3楼101单元) filed a patent application (PCT/CN2024/119856) for "USE OF ANTI-B7H3 ANTIBODY-DRUG CONJUGATE ...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: MEDILINK THERAPEUTICS (SUZHOU) CO., LTD., 苏州宜联生物医药有限公司 FILES APPLICATION FOR "USE OF ANTI-B7H3 ANTIBODY-DRUG CONJUGATE IN PREPARATION OF DRUG FOR TREATING NASOPHARYNGEAL CARCINOMA AND/OR LYMPHOEPITHELIOMA-LIKE CARCINOMA"